Stability of Reconstituted Amoxicillin and Potassium Clavulanate Oral Suspensions Marketed in the Democratic Republic of the Congo

Mankulu Kakumba Jocelyn, Mavanga Mabaya Timothy, Bayebila Menanzambi Tresor, Tshienda Katende Milka, Mbenza Puati Adelard, M. Jeremi, Kimbeni Malongo Tresor
{"title":"Stability of Reconstituted Amoxicillin and Potassium Clavulanate Oral Suspensions Marketed in the Democratic Republic of the Congo","authors":"Mankulu Kakumba Jocelyn, Mavanga Mabaya Timothy, Bayebila Menanzambi Tresor, Tshienda Katende Milka, Mbenza Puati Adelard, M. Jeremi, Kimbeni Malongo Tresor","doi":"10.11648/J.IJPC.20210701.12","DOIUrl":null,"url":null,"abstract":"Amoxicillin and Clavulanate potassium oral suspensions are one of antibiotics combination mainly available as dry powders for reconstitution. Made of a β-lactam molecule with a β-lactamase inhibitor, this combination existence can be justified by the potency of Clavulanate potassium which protects Amoxicillin against bacteria producing β-lactamases. Once reconstituted, suspension in single dose bag need to be taken by patient on daily basis following the medical prescription and the one in bottle to be taken according to the medical prescription and the remaining part (in the same container) kept refrigerated in order to get the optimal benefit from the drug. This study investigated the stability of Amoxicillin and Clavulanate potassium suspension both in bags (sachets) for single dose per daily-usage and in bottles for multiple dose usage. The last were reconstituted using distilled water and stored in refrigerator and the previous were instantly reconstituted before measurement. The stability evaluation was conducted on three brands (Six samples totally, two per brand including bottle and sachet for each brand) and for duration of seven days using a validated HPLC method. The evaluation was based on the measurement of pH values, color observation of reconstituted suspensions stored under refrigerator during 7 days and the active compounds concentrations determination. After analysis, no change was observed in pH values and a small change of color for multiple dose presentations stored in refrigerator. And the concentrations of suspensions evaluated in day 1 and day 7 showed over 90% up to seventh day under same storage conditions for both of the Amoxicillin and Clavulanate potassium pharmaceutical presentations. As the study aimed to assess the stability of the suspension in single-dose from bag presentation and in multiple-dose from suspension in bottle, we observed that the reconstituted suspension in distilled water of Amoxicillin + Clavulanate potassium stored in refrigerator is stable for seven days of use, independently from their pharmaceutical presentations either for oral suspensions (powders) in bottles or those in bags for single use after reconstitution.","PeriodicalId":14230,"journal":{"name":"International Journal of Pharmacy and Chemistry","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/J.IJPC.20210701.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Amoxicillin and Clavulanate potassium oral suspensions are one of antibiotics combination mainly available as dry powders for reconstitution. Made of a β-lactam molecule with a β-lactamase inhibitor, this combination existence can be justified by the potency of Clavulanate potassium which protects Amoxicillin against bacteria producing β-lactamases. Once reconstituted, suspension in single dose bag need to be taken by patient on daily basis following the medical prescription and the one in bottle to be taken according to the medical prescription and the remaining part (in the same container) kept refrigerated in order to get the optimal benefit from the drug. This study investigated the stability of Amoxicillin and Clavulanate potassium suspension both in bags (sachets) for single dose per daily-usage and in bottles for multiple dose usage. The last were reconstituted using distilled water and stored in refrigerator and the previous were instantly reconstituted before measurement. The stability evaluation was conducted on three brands (Six samples totally, two per brand including bottle and sachet for each brand) and for duration of seven days using a validated HPLC method. The evaluation was based on the measurement of pH values, color observation of reconstituted suspensions stored under refrigerator during 7 days and the active compounds concentrations determination. After analysis, no change was observed in pH values and a small change of color for multiple dose presentations stored in refrigerator. And the concentrations of suspensions evaluated in day 1 and day 7 showed over 90% up to seventh day under same storage conditions for both of the Amoxicillin and Clavulanate potassium pharmaceutical presentations. As the study aimed to assess the stability of the suspension in single-dose from bag presentation and in multiple-dose from suspension in bottle, we observed that the reconstituted suspension in distilled water of Amoxicillin + Clavulanate potassium stored in refrigerator is stable for seven days of use, independently from their pharmaceutical presentations either for oral suspensions (powders) in bottles or those in bags for single use after reconstitution.
在刚果民主共和国销售的重组阿莫西林和克拉维酸钾口服混悬液的稳定性
阿莫西林克拉维酸钾口服混悬液是一种主要以干粉形式重组的抗生素组合。由β-内酰胺分子和β-内酰胺酶抑制剂组成,这种组合的存在可以通过克拉维酸钾的效力来证明,克拉维酸钾可以保护阿莫西林免受产生β-内酰胺酶的细菌的侵害。混悬液一经配制,患者需按医嘱每日服用单剂量袋混悬液,按医嘱服用瓶装混悬液,其余部分(同一容器内)冷藏保存,以获得最佳的用药效果。本研究考察了阿莫西林和克拉维酸钾悬浮液的稳定性,包括每日单次使用的袋装(小袋)和多次使用的瓶装。后一种用蒸馏水复合后保存于冰箱中,前一种在测量前立即复合。采用经验证的高效液相色谱法对3个品牌(共6个样品,每个品牌2个样品,包括瓶子和小袋)进行了为期7天的稳定性评价。评价依据pH值测定、冰箱保存7 d的重组悬浮液颜色观察和活性成分浓度测定。经分析,在冰箱中保存多次剂量后,pH值没有变化,颜色也有很小的变化。在相同的储存条件下,阿莫西林和克拉维酸钾两种药物的悬浮液在第1天和第7天的浓度均超过90%。由于本研究的目的是评估单剂量袋装混悬液和多剂量瓶装混悬液的稳定性,我们观察到阿莫西林+克拉维酸钾在蒸馏水中重组的混悬液在冰箱中储存7天的稳定性,无论是瓶装口服混悬液(粉末状)还是重组后的袋装单次使用的混悬液,都与它们的药物形式无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信